It acts as an anti-cancer agent for inhibiting growth of endometrial, ovarian, and cervical cancer cells through mechanism by directly activating AMP-dependent protein kinase (AMPK) and subsequent suppressing mammalian targets of rapamycin (mTOR), thus, inhibiting global protein synthesis and proliferation in target cells14, 15. Here, MTOR is linked to cervical carcinoma.